These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 17978603)
1. Reducing cardiovascular events in high-risk patients: the challenge of managing hypertension in patients with diabetic renal disease. Toto RD J Clin Hypertens (Greenwich); 2007 Nov; 9(11 Suppl 4):16-25. PubMed ID: 17978603 [TBL] [Abstract][Full Text] [Related]
2. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. Burnier M; Zanchi A J Hypertens; 2006 Jan; 24(1):11-25. PubMed ID: 16331093 [TBL] [Abstract][Full Text] [Related]
3. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Reboldi G; Gentile G; Angeli F; Verdecchia P Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778 [TBL] [Abstract][Full Text] [Related]
4. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go? Sternlicht H; Bakris GL Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168 [TBL] [Abstract][Full Text] [Related]
5. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154 [TBL] [Abstract][Full Text] [Related]
6. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy. Jacobsen P; Rossing K; Parving HH Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491 [TBL] [Abstract][Full Text] [Related]
7. [Risk and prevention of diabetic nephropathy]. Ravera M; Re M; Deferrari G G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442 [TBL] [Abstract][Full Text] [Related]
8. The RAAS in the pathogenesis and treatment of diabetic nephropathy. Ruggenenti P; Cravedi P; Remuzzi G Nat Rev Nephrol; 2010 Jun; 6(6):319-30. PubMed ID: 20440277 [TBL] [Abstract][Full Text] [Related]
9. Blood pressure control in diabetic nephropathy. Katayama S Contrib Nephrol; 2001; (134):113-9. PubMed ID: 11665281 [No Abstract] [Full Text] [Related]
10. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension. Tocci G; Sciarretta S; Facciolo C; Volpe M Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654 [TBL] [Abstract][Full Text] [Related]
12. Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria. Lee GS Ann Acad Med Singap; 2005 Jan; 34(1):24-30. PubMed ID: 15726216 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
14. Albuminuria: a target for treatment of type 2 diabetic nephropathy. de Zeeuw D Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]
16. [Renin-angiotensin system in diabetic nephropathy]. Luño J Nefrologia; 2005; 25 Suppl 2():73-81. PubMed ID: 16050407 [TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors. Mercier K; Smith H; Biederman J Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533 [TBL] [Abstract][Full Text] [Related]
18. Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. Reboldi G; Gentile G; Angeli F; Verdecchia P Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1349-61. PubMed ID: 19900018 [TBL] [Abstract][Full Text] [Related]